PD-L1

Padding its lung cancer lead, Merck's Keytruda helped PD-L1 patients live 30 months longer
Padding its lung cancer lead, Merck's Keytruda helped PD-L1 patients live 30 months longer
Fierce Pharma
Merck
Keytruda
PD-L1
Flag link:
Bristol-Myers' Opdivo fails key lung cancer study, stocks ricochet
Bristol-Myers' Opdivo fails key lung cancer study, stocks ricochet
BioPharma Dive
Bristol-Myers Squibb
Opdivo
Merck Keytruda
non-small cell lung cancer
PD-L1
Flag link:
Merck KGaA/Pfizer analysis of PD-L1 drug for rare skin cancer shows encouraging interim results
Merck KGaA/Pfizer analysis of PD-L1 drug for rare skin cancer shows encouraging interim results
BioPharma Dive
Merck KGaA
Pfizer
PD-L1
Merkel cell carcinoma
Flag link:
Roche, Kite Pharma sign CAR-T and PD-L1 combo deal
Roche, Kite Pharma sign CAR-T and PD-L1 combo deal
Fierce Biotech
Roche
Kite Pharma
CAR-T
PD-L1
atezolizumab
KTE-C19
Flag link:
Roche's new PD-L1 bladder cancer drug could be on the market by September
Roche's new PD-L1 bladder cancer drug could be on the market by September
Fierce Biotech
Roche
PD-L1
bladder cancer
atezolizumab
Flag link:
Roche adds another positive snapshot for its PD-L1 checkpoint star 'atezo'
Roche adds another positive snapshot for its PD-L1 checkpoint star 'atezo'
Fierce Biotech
atezolizumab
Roche
PD-L1
triple negative breast cancer
Flag link:
Roche hustles to FDA with PhII PD-L1 cancer success for 'breakthrough' star atezo
Roche hustles to FDA with PhII PD-L1 cancer success for 'breakthrough' star atezo
Fierce Biotech
Roche
FDA
PD-L1
atezolizumab
Flag link:
Roche's new round of lung cancer data keeps spotlight on immunotherapies
Roche's new round of lung cancer data keeps spotlight on immunotherapies
Fierce Biotech
Roche
PD-L1
non-small cell lung cancer
MPDL3280A
lung cancer
Flag link:
Bristol Myers Squibb And The New Wave Of Cancer Drugs
Bristol Myers Squibb And The New Wave Of Cancer Drugs
Seeking Alpha
Bristol-Myers Squibb
Merck
nivolumab
lambrolizumab
Roche
PD-L1
melanoma
cancer
lung cancer
Flag link: